Practice Management

After more than three decades away from the cause, Brigham and Women’s Hospital cardiologist James Muller, MD, is back to warn a younger generation of physicians about the threat and potential consequences of nuclear war, the Boston Globe reports.

Oregon Health & Science University Hospital saw an “alarming” number of patient deaths in 2017, the year before its heart transplant program ultimately crumbled, new data has revealed.

The Centro Nacional de Investigaciones Cardiovasculares, a research foundation in Madrid, Spain, has coordinated the first international consensus document to streamline MRI protocol after myocardial infarction in clinical trials and experimental models.

Customized dashboards are helping health systems, hospitals and practices realize improvements in quality and cost of care.

The opportunities to bring in new money for non-face-to-face services are encouraging, but the requirements present obstacles.

Sometimes a move in the right direction starts with a good hard look in the rearview mirror, then breaking it off to start anew with greater wisdom.

Only half of the world’s countries offer cardiac rehabilitation programs, according to a recent survey, leaving some 18 million heart patients across the globe without access to therapy that could vastly improve their prognosis and quality of life.

Research published in Circulation: Cardiovascular Quality and Outcomes July 9 suggests the public health burden of pulseless in-hospital cardiac arrests is around 38% higher in adults and 18% higher in children than was previously believed.

Invasive cardiologists earn the top starting salary in medicine, according to a new report from Merritt Hawkins, raking in an average $648,000 in their first year of practice.

Heart patients of a lower socioeconomic status are far more likely to participate in cardiac rehabilitation if they receive financial incentives to attend sessions, according to a study published in the July 1 edition of JACC: Heart Failure.

Fear-based “fake news” about statin therapy is driving non-adherence to the drugs in the U.S., according to an editorial published in JAMA Cardiology June 26, fostering a culture of mistrust and misinformation that could easily deter heart patients from a treatment that might be beneficial to them.

The Massachusetts Medical Society, which publishes the New England Journal of Medicine, on June 19 named Eric J. Rubin, MD, PhD, as the newest editor-in-chief of the Journal and NEJM Group.